For research purposes only
CJC/IPA
CJC/IPA is a research blend pairing CJC no DAC, a GHRH receptor agonist, with Ipamorelin, a selective GHS-R1a agonist, in a single lyophilized format. Because the two peptides target distinct receptor subtypes, they engage complementary somatotroph signaling arms: CJC no DAC through the cAMP-PKA cascade and Ipamorelin through phospholipase C. This dual-receptor configuration is used in GH-axis research to characterize synergistic crosstalk between pituitary receptor populations within a common experimental system. Supplied lyophilized for in vitro research use only.
Select size
$65.00
Specifications
- CAS
- Blend
- MW
- Mixed
- Formula
- Blend
- Purity
- >=99.0 HPLC
- Storage
- -20 °C, lyophilized
Research Notes
What is CJC/IPA?
CJC/IPA is a synthetic research compound studied in laboratory settings. It is intended for in vitro research use only and is not for human or animal use.
What purity is METATIDE's CJC/IPA?
METATIDE supplies CJC/IPA at >=99.0% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is CJC/IPA supplied?
CJC/IPA is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.